Correlation Between Eliem Therapeutics and Sutro Biopharma
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Sutro Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Sutro Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Sutro Biopharma, you can compare the effects of market volatilities on Eliem Therapeutics and Sutro Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Sutro Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Sutro Biopharma.
Diversification Opportunities for Eliem Therapeutics and Sutro Biopharma
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and Sutro is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Sutro Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sutro Biopharma and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Sutro Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sutro Biopharma has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Sutro Biopharma go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Sutro Biopharma
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Sutro Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.29 times less risky than Sutro Biopharma. The stock trades about -0.22 of its potential returns per unit of risk. The Sutro Biopharma is currently generating about -0.17 of returns per unit of risk over similar time horizon. If you would invest 356.00 in Sutro Biopharma on August 31, 2024 and sell it today you would lose (87.00) from holding Sutro Biopharma or give up 24.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Eliem Therapeutics vs. Sutro Biopharma
Performance |
| Timeline |
| Eliem Therapeutics |
| Sutro Biopharma |
Eliem Therapeutics and Sutro Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Sutro Biopharma
The main advantage of trading using opposite Eliem Therapeutics and Sutro Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Sutro Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will offset losses from the drop in Sutro Biopharma's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Sutro Biopharma vs. Cue Biopharma | Sutro Biopharma vs. Eliem Therapeutics | Sutro Biopharma vs. Inhibrx | Sutro Biopharma vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |